We are live on ! Find out more
MEDP icon

Medpace

144 hedge funds and large institutions have $612M invested in Medpace in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 61 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

413% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 8

144% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 25

83% more capital invested

Capital invested by funds: $335M → $612M (+$277M)

27% more funds holding

Funds holding: 113144 (+31)

13.01% more ownership

Funds ownership: 27.04%40.06% (+13%)

Holders
144
Holders Change
+31
Holders Change %
+27.43%
% of All Funds
3.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
41
Increased
61
Reduced
25
Closed
8
Calls
$1.47M
Puts
Net Calls
+$1.47M
Net Calls Change
+$125K
Name Holding Trade Value Shares
Change
Change in
Stake
Mackenzie Financial
26
Mackenzie Financial
Ontario, Canada
$5.22M -$32.3K -800 -0.7%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$4.76M +$3.22M +79,636 +257%
JP Morgan Chase
28
JP Morgan Chase
New York
$4.55M +$2.44M +60,524 +134%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$4.47M -$291K -7,209 -6%
Norges Bank
30
Norges Bank
Norway
$4.44M +$2.67M +66,213 +179%
Janus Henderson Group
31
Janus Henderson Group
United Kingdom
$4.33M +$4.07M +100,680 New
OAM
32
Oxford Asset Management
United Kingdom
$4.28M +$1.05M +25,973 +35%
Fisher Asset Management
33
Fisher Asset Management
Washington
$4.26M -$1.2M -29,663 -23%
Goldman Sachs
34
Goldman Sachs
New York
$4.23M +$2.29M +56,673 +136%
Millennium Management
35
Millennium Management
New York
$3.81M +$3.58M +88,651 New
Charles Schwab
36
Charles Schwab
California
$3.73M +$546K +13,518 +18%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.67M +$141K +3,486 +4%
GCP
38
GSA Capital Partners
United Kingdom
$3.66M +$1.75M +43,300 +103%
Allianz Asset Management
39
Allianz Asset Management
Germany
$3.58M -$42.6K -1,055 -1%
Arrowstreet Capital
40
Arrowstreet Capital
Massachusetts
$3.33M +$2.34M +57,940 +297%
Morgan Stanley
41
Morgan Stanley
New York
$3.07M +$529K +13,106 +22%
PP
42
PDT Partners
New York
$2.92M +$485K +12,000 +21%
First Trust Advisors
43
First Trust Advisors
Illinois
$2.85M +$2.67M +66,182 New
PPA
44
Parametric Portfolio Associates
Washington
$2.71M +$1.69M +41,736 +196%
PAM
45
Panagora Asset Management
Massachusetts
$2.51M +$134K +3,322 +6%
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$2.36M +$1.89M +46,890 +593%
AI
47
Axiom Investors
Connecticut
$2.34M +$2.2M +54,450 New
TCIM
48
TIAA CREF Investment Management
New York
$2.21M +$55.6K +1,376 +3%
3C
49
361 Capital
Colorado
$1.86M +$56.7K +1,403 +3%
MWNA
50
Marshall Wace North America
New York
$1.85M -$1.22M -30,237 -41%

MEDP Hedge Fund Activity: Q2 2018 in Review

144 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2018, worth a combined $612M — up 83% from $335M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MEDP positions and 8 closed out — a net gain of 33 holders — while 61 added to existing stakes and 25 trimmed.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $27.5M. The largest seller was Bernzott Capital Advisors, cutting an estimated $8.29M.

  • 144 institutional investors held Medpace (MEDP) as of Q2 2018, up from 113 in Q1 2018.
  • Funds reported $612M of Medpace stock for Q2 2018, up 83% quarter-over-quarter.
  • 41 funds opened new Medpace positions in Q2 2018 and 8 closed out, a net change of +33 holders.
  • The largest Medpace buyer in Q2 2018 was Laurion Capital Management, an estimated $27.5M added.
  • The largest Medpace seller in Q2 2018 was Bernzott Capital Advisors, an estimated $8.29M sold.

Based on aggregated 13F filings for Q2 2018.